PrimeBioMed Overview

  • Founded
  • 2013
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 2

PrimeBioMed General Information


Developer of molecular-cell diagnostic technology intended to develop antibodies for cancer diagnosis. The company's technology uses recombinant diagnosis and long-established hybridoma lines for the development of antibodies, enabling the healthcare industry to treat cancer easily.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Nauchny pr. 20, p. 3
  • Moscow, 117246
  • Russia
+7 8 (000) 000-00-00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PrimeBioMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 25-Sep-2017 00.000 Completed Generating Revenue
2. Early Stage VC 00.000 Completed Startup
1. Early Stage VC (Series A) 01-Jan-2013 $2.02M $2.02M Completed Startup
To view PrimeBioMed’s complete valuation and funding history, request access »

PrimeBioMed Executive Team (3)

Name Title Board Seat Contact Info
Alexey Grachev Ph.D Co-Founder, General Director & Chief Executive Officer
Juliya Kzhyshkovska Co-Founder
Olga Lopaeva Co-Founder
To view PrimeBioMed’s complete executive team members history, request access »

PrimeBioMed Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PrimeBioMed Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Russian Venture Company Venture Capital Majority 000 0000 000000 0
Skolkovo Foundation Limited Partner Minority 000 0000 000000 0
To view PrimeBioMed’s complete investors history, request access »